Abstract
Providing support for downstream drug development has not traditionally been a primary focus of public research funding programmes. However, the European Commission has decided to include the drug development process in the European Union's Sixth Framework Programme for Research and Technological Development (2002–2006). If the present proposal is adopted, research consortia and networks must be ready to exploit the proposed funds. 'Integrated Projects' and 'Networks of Excellence' will allow complex topics to be tackled simultaneously by many research groups and associated stakeholders, but these will be very demanding to implement.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Bjerrum, O. J. New Safe Medicines Faster: a proposal for a key action within the European Union's 6th Framework Programme. Pharmacol. Toxicol. 86, 23–26 (2000).
Alderborn, G. et al. New Safe Medicines Faster. Proposals for research topics, methodologies, techniques and other means of promoting the drug development process to the benefit of European citizens. EUFEPS Online [online] (cited 18 Mar 02).
Anonymous. Proposal for Council decisions concerning the specific programmes implementing the Framework Programme 2002–2006 of the European Community for research, technological development and demonstration activities. [online] (cited 18 Mar 02) (2002).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bjerrum, O. New Safe Medicines Faster: a proposition for a pan-European research effort. Nat Rev Drug Discov 1, 395–398 (2002). https://doi.org/10.1038/nrd797
Issue Date:
DOI: https://doi.org/10.1038/nrd797
